Particle.news

Download on the App Store

USADA Suspends Karl Moore for One Year Over rEPO, Citing ‘Reckless’ Injection

USADA raised the penalty to the policy maximum due to his injection of an unlabeled drug.

Image

Overview

  • An out-of-competition sample collected on April 9, 2025 tested positive for recombinant erythropoietin.
  • The suspension is backdated to April 9, 2025, making Moore eligible to compete again on or after April 9, 2026.
  • USADA cited his injection of an unlabeled drug that was not his as the aggravating factor under the PFL Anti-Doping Policy, which sets six months as the default for a first offense.
  • Multiple outlets report the Professional Fighters League has released Moore from his contract prior to the public announcement.
  • Moore, 33, last fought on May 1, losing a split decision to Antonio Carlos Jr., and rEPO is banned at all times for its endurance-enhancing effects.